Wegovy price without insurance
Wegovy contains semaglutide and is made by Novo Nordisk. Its lowest current self-pay price is $149/mo for the tablet, across 6 sourced offers. Prices below are by form and dose, each with its seller, conditions and check date.
Wegovy injection
Once weekly
Advertised entry price
$199/fill initially≈ $213.21 per 30 days at this quoted rate
Offer through
Checked
Wegovy pen (standard doses 0.25-2.4 mg)
NovoCare (Novo Nordisk) · Manufacturer direct
first two monthly fills at 0.25 or 0.5 mg for new patients, prescribed by Dec 31, 2026
Price conditions
first two monthly fills at 0.25 or 0.5 mg for new patients, prescribed by Dec 31, 2026
After the introductory offer, standard doses cost $349 per box of four weekly pens. Wegovy HD (7.2 mg) is $399. Eligibility and restrictions apply.
28-day supply
Published maintenance dose
$349/28 days≈ $373.93 per 30 days at this quoted rate
Checked
At 2.4 mg
Wegovy pen (standard doses 0.25-2.4 mg)
NovoCare (Novo Nordisk) · Manufacturer direct
Published price at 2.4 mg
Price conditions
Published price at 2.4 mg
After the introductory offer, standard doses cost $349 per box of four weekly pens. Wegovy HD (7.2 mg) is $399. Eligibility and restrictions apply.
One price for every standard dose (0.25-2.4 mg).
28-day supply
Wegovy tablet
Once daily, on an empty stomach
Advertised entry price
from $149/mo$149 per 30 days at this quoted rate
Checked
Wegovy pill (oral semaglutide)
NovoCare (Novo Nordisk) · Manufacturer direct
self-pay cash, lowest dose (1.5 mg)
Price conditions
self-pay cash, lowest dose (1.5 mg)
$149/mo for 1.5 mg; $199 for 4 mg (the 4 mg $149 promo ended Aug 31, 2026); $299 for 9 mg and 25 mg.
30-day supply
Every cash quote was checked on or after . Each quote shows its own check date. A quoted dose is not a dosing recommendation. How we source prices
All Wegovy offers
Manufacturer, pharmacy and telehealth quotes for Wegovy itself. Compounded semaglutide is a different, unapproved product and is listed on the main price page.
Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.
Compare every GLP-1 priceWhat Wegovy showed in trials
Each result belongs to its named trial and dose. Trial averages do not predict an individual's result.
Wegovy injection
−14.9% (-14.9% at 68 wks · STEP 1 · 2.4 mg weekly (Wegovy))STEP 1 · -14.9% at 68 wks
2.4 mg weekly (Wegovy)
Accounts for treatment discontinuation
Wegovy tablet
−13.6% (-13.6% at 64 wks · OASIS 4 · 25 mg daily (Wegovy tablet))OASIS 4 · -13.6% at 64 wks
25 mg daily (Wegovy tablet)
Accounts for treatment discontinuation
Approved uses
Eligibility, contraindications and warnings are in the full prescribing information.
Wegovy injection
Weight management in eligible adults and adolescents 12+ with obesity; cardiovascular risk reduction in eligible adults; noncirrhotic MASH with moderate to advanced liver fibrosis in adults (accelerated approval).
US prescribing information (Wegovy Injection prescribing information)Reviewed Sep 6, 2026
Wegovy tablet
Weight management and cardiovascular risk reduction in eligible adults. The tablet is not labeled for MASH or pediatric use.
US prescribing information (Wegovy Tablet prescribing information)Reviewed Sep 6, 2026
Is Wegovy in shortage?
No shortage is listed in the latest complete FDA check. The FDA does list discontinuation notices for specific presentations. This status covers semaglutide as a whole; last complete check Oct 9, 2026. National reporting does not confirm stock at your pharmacy.
All GLP-1 shortage reportsWegovy cost: common questions
How much does Wegovy cost without insurance?
Injection: $199/fill initially at NovoCare (Novo Nordisk) (≈ $213.21 per 30 days at this quoted rate); $349/28 days at 2.4 mg. Tablet: from $149/mo at NovoCare (Novo Nordisk) ($149 per 30 days at this quoted rate); $299/mo at 25 mg. These are self-pay prices from the sellers' own pages, not insurance estimates; the conditions and refill rules listed with each quote apply.
What is Wegovy approved for?
Injection: Weight management in eligible adults and adolescents 12+ with obesity; cardiovascular risk reduction in eligible adults; noncirrhotic MASH with moderate to advanced liver fibrosis in adults (accelerated approval). Tablet: Weight management and cardiovascular risk reduction in eligible adults. The tablet is not labeled for MASH or pediatric use.